GLP-1 Lawsuits: Legal Help for Ozempic, Wegovy, Mounjaro, Trulicity, and Rybelsus Injuries

People who took a GLP-1 drug such as Ozempic, Wegovy, Mounjaro, Trulicity, or Rybelsus and later suffered severe stomach paralysis (gastroparesis), bowel obstruction, ileus, or pancreatitis may be eligible to file a lawsuit against Novo Nordisk or Eli Lilly. Federal cases were consolidated into a multidistrict litigation (MDL) in February 2024, and bellwether trials have been expected in 2026.

Based on comparable pharmaceutical litigation, estimated case values range from about $10,000 for minor, short-term injuries to $1 million or more for catastrophic or fatal cases. In California, you generally have two years to file, starting from when you discovered or reasonably should have discovered the link between your injury and the drug. Contact Walch Law for a free, confidential case review.

GLP-1 drugs have become some of the most prescribed medications in the country. Millions of people take them to manage type 2 diabetes or lose weight, and many have seen real health benefits.

But a growing number of patients say they paid a steep price- they describe constant vomiting, being unable to keep food down, emergency surgery for blocked intestines, and weeks in the hospital. Many say no one ever told them these drugs could cause injuries this serious. Call Walch Law NOW to learn more and get started for free today.

What Are GLP-1 Drugs?

GLP-1 receptor agonists are medications that mimic glucagon-like peptide-1, a hormone your body releases after eating. They help control blood sugar, reduce appetite, and slow how quickly food leaves your stomach.

That last effect, slowed digestion, is central to the lawsuits. Plaintiffs allege the drugs can slow the digestive system so much that it stops working properly.

The drugs named in current litigation include:

Related drugs, such as Zepbound, Saxenda, and Victoza, may also be part of some claims. If you took any GLP-1 medication and suffered a serious digestive injury, it’s worth having your case reviewed.

Serious Side Effects Linked to GLP-1 Drugs

Nausea and mild stomach upset are common and listed on the labels. The lawsuits focus on something far more serious: injuries that send people to the hospital, require surgery, or cause lasting harm.

Gastroparesis (Stomach Paralysis)

Gastroparesis happens when the stomach muscles stop moving food into the small intestine the way they should. Food sits in the stomach for hours or even days. Symptoms include:

• Severe, persistent nausea and vomiting
• Vomiting undigested food hours after eating
• Feeling full after just a few bites
• Painful bloating and abdominal pain
• Dehydration and malnutrition
• Unintended, unhealthy weight loss

For some patients, symptoms continue even after they stop the medication. Severe cases may require feeding tubes, IV nutrition, or surgical procedures.

Bowel Obstruction and Ileus

An ileus is a condition where the intestines stop moving contents through the digestive tract. A bowel obstruction is a blockage that prevents food, fluid, and gas from passing. Both can be life-threatening.

In 2023, the FDA updated the Ozempic label to include ileus based on reports received after the drug was approved. Plaintiffs argue that warning came too late for many patients.

Signs of an obstruction or ileus include severe cramping, a swollen belly, inability to pass gas or stool, and vomiting. Treatment often requires hospitalization, a nasogastric tube, and sometimes emergency surgery to remove part of the intestine.

Pancreatitis

Acute pancreatitis is inflammation of the pancreas. It causes intense upper abdominal pain that often spreads to the back, along with fever, nausea, and vomiting. Severe cases can lead to organ failure, infection, and death. Some patients develop chronic pancreatitis with long-term digestive and blood sugar problems.

Other Reported Injuries

Claims have also involved:

• Gallbladder disease, including gallstones and gallbladder removal
• Aspiration during anesthesia, when stomach contents enter the lungs during surgery because the stomach didn’t empty
• Severe dehydration and kidney injury from prolonged vomiting
• Vision loss, including a condition called non-arteritic anterior ischemic optic neuropathy (NAION), which is being investigated in separate claims

The Core Legal Claim: Failure to Warn

Drug companies have a duty to warn doctors and patients about serious risks. The GLP-1 lawsuits allege that Novo Nordisk and Eli Lilly knew, or should have known, that their drugs could cause severe gastrointestinal injuries and failed to warn about them adequately.

Plaintiffs argue that the labels described mild stomach upset but didn’t make clear that patients could suffer stomach paralysis, intestinal blockages, or injuries requiring surgery. Had patients and doctors known the true risks, many say they would have chosen a different treatment or watched for warning signs sooner.

Current Status of the GLP-1 MDL

How the Federal Cases Are Organized

On February 2, 2024, the Judicial Panel on Multidistrict Litigation consolidated federal GLP-1 lawsuits into a single proceeding: In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094. The MDL sits in the U.S. District Court for the Eastern District of Pennsylvania.

The MDL started with 55 cases. It has since grown to thousands of claims as more patients come forward.

An MDL is not a class action. Each person keeps their own individual lawsuit. The MDL lets one judge manage shared issues, such as evidence from the drug companies and expert testimony, so cases move more efficiently. Your compensation is still based on your own injuries.

Key Issues the Court Is Deciding

The court has spent much of the litigation on cross-cutting questions that affect many cases at once. One of the most important is how a plaintiff proves a gastroparesis diagnosis. Objective medical testing, such as a gastric emptying study, is likely to carry significant weight. That makes your medical records, and the right testing, essential to a strong claim.

Bellwether Trials

Bellwether trials are early test cases that show both sides how juries may respond to the evidence. Legal analysts have expected the first GLP-1 bellwether trials to take place in 2026. Their outcomes often shape settlement negotiations for every other case in the MDL.

Has There Been a Settlement?

As of this writing, there is no global GLP-1 settlement, and no jury has found that these medications caused anyone’s injury. The litigation is ongoing. That’s important for two reasons. First, any dollar figures you see, including the estimates below, are projections rather than settled amounts. Second, now is the time to get your claim filed and documented so you’re in position when resolution comes.

How Much Is a GLP-1 Lawsuit Worth?

This is often the first question people ask when they come to Walch Law for their GLP-1 legal help, and you deserve a straight answer.

Because no global settlement has been reached, no attorney can tell you exactly what GLP-1 claims will pay. What we can do is estimate value based on how settlements have been structured in comparable pharmaceutical mass torts. Those settlements typically use tiers, with payouts rising as injuries become more severe, permanent, or invasive to treat.

The ranges below are estimates only. They are not guarantees, and your case could fall above or below them.

Estimated GLP-1 Case Values by Injury Severity

Factors That Can Raise or Lower Your Case Value

Within any tier, several factors can move your number up or down:

• Objective diagnosis. A gastric emptying study, CT scan, endoscopy, or surgical report strengthens your claim.
• Length of hospitalization. Every additional day in the hospital adds medical costs and supports higher non-economic damages.
• Surgery. Cases involving surgical treatment are typically valued much higher.
• Permanence. Symptoms that continue after stopping the drug carry more value than injuries that resolved.
• Timing. A clear timeline between starting the drug, dose increases, and symptom onset helps prove causation.
• Lost income. Missed work and reduced earning capacity add economic damages.
• Age and health history. Pre-existing digestive conditions, such as diabetic gastroparesis, can complicate a claim. Defendants often argue that diabetes itself caused the problem.
• Quality of documentation. Well-organized pharmacy, medical, and billing records can make a real difference. This is where the best GLP-1 lawyer can really help- make sure you are picking the right firm.

What Compensation Can Include

Economic damages:

• Hospital stays, emergency care, and surgery
• Diagnostic tests, including gastric emptying studies and imaging
• Ongoing treatment, medications, and specialist visits
• Feeding tubes, IV nutrition, or home health care
• Lost wages and reduced future earning capacity

Non-economic damages:

• Physical pain and suffering
• Emotional distress and anxiety
• Loss of enjoyment of life, including the inability to eat normally
• Strain on relationships and daily activities

Wrongful death damages:

• Funeral and burial expenses
• Loss of financial support
• Loss of love, companionship, and guidance

Why Hire Walch Law for Your GLP-1 Case

Taking on Novo Nordisk and Eli Lilly means going up against two of the largest pharmaceutical companies in the world. They have deep resources and large defense teams. You deserve a legal team that’s ready for that fight and treats you like a person, not a case number.

We Build Your Case Around Strong Medical Proof

GLP-1 cases are won or lost on medical evidence. The defense will argue that your symptoms came from diabetes, diet, or another condition. We gather your pharmacy records, prescription history, hospital records, imaging, and test results to build a clear timeline linking the drug to your injury. If your records are missing key testing, we’ll explain what may help strengthen your claim.

We Track the MDL So You Don’t Have To

Court rulings, filing requirements, and settlement terms in an MDL can change quickly. We follow every development in the GLP-1 litigation and keep you updated on what it means for your case. You won’t miss a deadline or a key decision because you didn’t hear about it.

CALL WALCH LAW NOW.